Chiropractors in Columbus, NJ Accepting Medicare
5 Chiropractors found. Showing 1 - 5
 Dr. Nicholas Andrew Puccio, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 45 Homestead Dr, Suite A, Columbus, NJ 08022 Phone: 609-324-7778 Fax: 609-324-7742 |
 Ikeda Family Chiropractic Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 23659 Columbus Rd, Suite 2a, Columbus, NJ 08022 Phone: 609-298-7700 Fax: 609-298-7724 |
 Dr. Hannah Mcintyre, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 24548 E Main St # 104a, Columbus, NJ 08022 Phone: 609-306-4872 |
Dr. David W Ikeda, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 23659 Columbus Rd, Suite 2a, Columbus, NJ 08022 Phone: 609-298-7700 Fax: 609-298-7724 |
Puccio Chiropractic Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 45 Homestead Dr, Suite A, Columbus, NJ 08022 Phone: 609-324-7778 Fax: 609-324-7742 |
News Archive
Researchers use hydrogels to induce significant vasculature growth in areas of damaged tissue
Regenerative medicine therapies often require the growth of functional, stable blood vessels at the site of an injury. Using synthetic polymers called hydrogels, researchers at the Georgia Institute of Technology have been able to induce significant vasculature growth in areas of damaged tissue.
Reductions in pressure injury prevalence linked to improved preventive practices
Rates of new pressure injuries in U.S. hospitals and other acute care settings have decreased by about half over the past decade, according to national survey data reported in the Journal of Wound, Ostomy and Continence Nursing.
Invida to continue commercialization of Actelion's Tracleer for PAH in crucial Asian markets
Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong
NPS submits NDA CMC section to FDA for GATTEX
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has submitted the chemistry, manufacturing and controls (CMC) section of its new drug application (NDA) for GATTEX® (teduglutide) to the U.S. Food and Drug Administration (FDA).
› Verified 6 days ago
Physical Therapists
Chiropractors
Occupational Therapists
Speech-Language Pathologists
Optometrists
Podiatrists